{
    "clinical_study": {
        "@rank": "152946", 
        "arm_group": {
            "arm_group_label": "Cohort"
        }, 
        "brief_summary": {
            "textblock": "This observational study will evaluate the impact of rash on survival of patients with\n      metastatic pancreatic cancer treated with Tarceva (erlotinib) plus gemcitabine. Further,\n      clinical effectiveness, efficacy and safety will be assessed. Data will be collected for 12\n      months."
        }, 
        "brief_title": "An Observational Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Pancreatic Cancer", 
        "condition_browse": {
            "mesh_term": "Pancreatic Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients, age >= 18 years\n\n          -  Patients with metastatic pancreatic cancer where investigators have decided to give a\n             combination therapy Tarceva and gemcitabine according to Summary of Product\n             Characteristics (SmPC)\n\n          -  Written and signed informed consent prior to onset of documentation\n\n        Exclusion Criteria:\n\n          -  Contraindications for Tarceva according to Summary of Products Characteristics (SmPC)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with metastatic pancreatic cancer"
            }
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01782690", 
            "org_study_id": "ML23024"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Gemcitabine", 
                "Erlotinib"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "May 5, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "K\u00f6ln", 
                    "country": "Germany", 
                    "zip": "50937"
                }
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Impact on Survival of Cutaneous Reactions in Erlotinib Plus Gemcitabine Treated Patients With Metastatic Pancreatic Cancer Under Conditions of Daily Routine Practice", 
        "overall_contact": {
            "email": "global.rochegenentechtrials@roche.com", 
            "last_name": "Reference Study ID Number: ML23024 www.roche.com/about_roche/roche_worldwide.htm", 
            "phone": "888-662-6728 (U.S. Only)"
        }, 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices (Bfarm)"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Overall survival stratified by rash", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01782690"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence and severity of rash", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Safety: incidence of adverse events", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Reasons for dose modification/withdrawals", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Management of rash symptoms", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Clinical effectiveness in patients with Eastern Oncology Group Performance Status (ECOG PS) 2", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Response rate", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Time to disease progression", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Treatment satisfaction assessed by patient questionnaire", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}